Infection Intel

>

Latest News

Hepatitis B virus (Adobe Stock 239268660 by Destina)
Advancing Viral Disease Treatment of Recurrent Genital Herpes, Hepatitis B and D Viruses

May 2nd 2024

Health care has an unmet need for the treatment of herpesviruses, hepatitis B, and hepatitis D, which would enhance patient outcomes. What should be done, and what challenges do companies that are trying to develop treatments face?

Weekly Rounds With Infection Control Today
Weekly Rounds: Care Coordination Is Too Complex, Operating Room Traffic, Diabetes, and More

February 9th 2024

Infection Control Today's Infection Intel: Staying Ahead With Company Updates and Product Innovations.
Combatting Infectious Diseases: FendX's Nanotechnology Innovations in Surface Protection

February 6th 2024

Weekly Rounds with Infection Control Today
Weekly Rounds: Challenging MRSA Precautions, Bug of the Month, and More

December 8th 2023

Infection Control Today's Infection Intel
Infection Intel: BiomX, SHEA, CSL and Arcturus Therapeutics

December 5th 2023

More News

Weekly Rounds With Infection Control Today

Weekly Rounds: Preventing Respiratory Diseases in Pregnancy, Diabetes Awareness Month, and More

December 1st 2023

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending December 3, 2023.

Infection Intel: Staying Ahead with Company Updates and Product Innovations

GigaGen Expands Contract With US Department of Defense for Synthetic Antibody Treatments for Botulinum Neurotoxins

Infection Control Today® Editorial Staff
November 27th 2023

GigaGen, a biotech company, secures an $11.8M contract expansion with the US Department of Defense to develop synthetic human antibody treatments for botulinum neurotoxins.

weekly rounds with infection control today

Weekly Rounds: Happy Thanksgiving Weekend! AMR, Class Action Lawsuits, and More

November 24th 2023

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending November 25, 2023.

Weekly Rounds with Infection Control Today

Weekly Rounds: Facelift Surgery, Rhinovirus Outbreak, Infection Intel and More

November 17th 2023

Take 5 minutes to catch up on Infection Control Today®’s highlights for the week ending November 19, 2023.

Infection Control Today Infection Intel: Staying Ahead With Regulatory Updates and Product Innovations

Infection Intel: AstraZeneca, DayZero and Oxford Nanopore, and More

November 14th 2023

Staying Ahead with Company Updates and Product Innovations. This week's news is from AstraZeneca, DayZero and Oxford Nanopore, Ohmnilab, and NIH.